EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide

Solon Andrades da Rosa iD, Henrique Quaiato de Oliveira iD, Laura Boose de Mendonça, Nicole Borgmann de Oliveira, Mariane da Cunha Jaeger, Luiza Cherobini Pereira, Fernanda Dittrich Pinto Oliveira, Debora Santos-Sousa, Fernanda Saez-Calazans, Luana Lenz iD, Melike Lakadamyali, Guido Lenz und 1 weitere

Aging Cell · 2026-04 · 25 (4)

DOI: 10.1111/acel.70477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 10.04.2026. Verfasst von Solon Andrades da Rosa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação Em Biologia Celular e Molecular, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Cellular Senescence, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre (ROR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several chemotherapeutics induce cancer cells to senescence, a persistent growth‐arrest state associated with poor cancer prognosis. Relevant features in cancer cell biology, such as phenotypic plasticity and intercellular variability, are poorly understood for senescent cells (SnCs). This study examined the morphofunctional heterogeneity and dynamics of glioblastoma cells induced to senescence by Temozolomide (TMZ), focusing on pro‐survival mechanisms, including autophagy and anti‐apoptotic proteins, and phenotypic plasticity. TMZ triggered a proliferative arrest with canonical features of senescence. Two distinct morphotypes emerged with different kinetics: extension‐rich (E‐state) cells, which were predominant early on, and flattened (F‐state) cells, which accumulated over time. These states were interchangeable, mostly from E‐state to F‐state, as revealed by single‐cell tracking. F‐state cells exhibited progressive enlargement of cellular and nuclear area, beyond extended survival, suggesting a more stable senescent phenotype despite lower p16 and autophagy levels than E‐state cells. Late autophagy inhibition using hydroxychloroquine broadly sensitized both morphotypes, reducing enlarged cells. Otherwise, early autophagy inhibition with 3‐methyladenine was not cytotoxic but led to E‐state accumulation over F‐state cells, suggesting an impact on morphometric dynamics. Beyond autophagy and p16, F‐state cells also expressed lower levels of anti‐apoptotic Bcl‐2 proteins, indicating differential activation of survival pathways. Notably, the senolytics dasatinib preferentially eliminated E‐state cells. These findings highlight the plasticity and heterogeneity of TMZ‐induced senescent glioblastoma cells and emphasize the need for selective senotherapeutic strategies aiming to attenuate the pro‐tumor effects exerted by SnCs on the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaCellular SenescenceBrain NeoplasmsHumansAutophagyCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

autophagycellular senescenceheterogeneityphenotypic plasticitysenolytics

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Programa de Pós-Graduação Em Biologia Celular e Molecular, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Departamento de Biofísica, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Instituto Do Câncer Infantil, Porto Alegre, Rio Grande do Sul, Brazil.
  • Programa de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
  • Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Solon Andrades da Rosa, Henrique Quaiato de Oliveira, Luana Lenz, Eduardo Cremonese Filippi-Chiela

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Hospital de Clínicas de Porto Alegre (ROR)

Zitieren

APA

da Rosa, S. A., de Oliveira, H. Q., de Mendonça, L. B., de Oliveira, N. B., Jaeger, M. D. C., Pereira, L. C., Oliveira, F. D. P., Santos-Sousa, D., Saez-Calazans, F., Lenz, L., Lakadamyali, M., Lenz, G., & Filippi-Chiela, E. C. (2026). Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide. Aging Cell, 25(4). https://doi.org/10.1111/acel.70477

Vancouver

da Rosa SA, de Oliveira HQ, de Mendonça LB, de Oliveira NB, Jaeger MDC, Pereira LC, et al. Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide. Aging Cell. 2026;25(4). doi:10.1111/acel.70477

BibTeX
@article{daRosa2026,
  author = {da Rosa, Solon Andrades and de Oliveira, Henrique Quaiato and de Mendonça, Laura Boose and de Oliveira, Nicole Borgmann and Jaeger, Mariane da Cunha and Pereira, Luiza Cherobini and Oliveira, Fernanda Dittrich Pinto and Santos-Sousa, Debora and Saez-Calazans, Fernanda and Lenz, Luana and Lakadamyali, Melike and Lenz, Guido and Filippi-Chiela, Eduardo Cremonese},
  title = {Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {4},
  doi = {10.1111/acel.70477}
}
Kostenlos starten →